Evvy
PrivateLast Round
Series B
Sep 15, 2026
Total Funding Raised
$59M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Evvy operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in September 2026.
Evvy is a healthtech company that provides an at-home testing platform to analyze the vaginal microbiome and deliver personalized health insights and care plans.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, D2C Brands, Medical AI, Telemedicine, Subscription Commerce
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evvy Comparables
Compare Evvy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Daye | 82% | |
| Juno Bio | 79% | |
| Psomagen, Inc. | 77% |
For institutional investors. Book with your work email.
Evvy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 15, 2026 | ||||
| Series A | Sep 27, 2023 | ||||
| Seed | Jul 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evvy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foreground Capital | Series B |
| Human Ventures | Seed |
| BBG Ventures | Seed, Series B |
| Rethink Impact | Series B |
| Catalio Capital Management | Series B |
| Muse Capital | Series B |
| General Catalyst | Series A, Series B, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
$40M round led by Catalio Capital Management.
- Jan 28, 2026
Recognized by The Webby Awards.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 16, 2026
Evvy is developing EvvyAI, a machine-learning platform for clinical decision-making, in New York as it expands research into fertility and other women's health conditions on Sep 16th '26.
- partners_withSep 16, 2026
Evvy plans to continue collaborating with US Fertility to advance research on the role of the vaginal microbiome in fertility and reproductive health on Sep 16th '26.
- is_developingSep 16, 2026
Evvy plans to pursue clinical validation of new EvvyAI-powered diagnostic and care models across women's health conditions, expand distribution through physicians and partner channels, and continue its collaboration with US Fertility in Sep '26.
- receives_financingSep 16, 2026
On Sep 15th '26, Evvy raises a $40M Series B led by Catalio Capital Management, with participation from new and returning investors, to expand its vaginal microbiome platform into fertility diagnostics in New York.
- is_developingSep 15, 2026
Evvy is poised to expand its research capabilities and develop new products and services that can improve women's health outcomes after raising a $40 million Series B led by Catalio Capital Management on Sep 15th '26.
For institutional investors. Book with your work email.
Evvy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evvy's valuation, stock price, and market status.
Is Evvy a public or private company?
Evvy is a private company.
What is the current stock price of Evvy?
Evvy is a private company, so its shares have no public market price. Caplight tracks Evvy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evvy worth (valuation)?
Valuation information for Evvy is not publicly available.
Can I buy Evvy stock?
Evvy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evvy's last funding round?
Evvy's most recent funding round was Series B on September 15, 2026.
Who are the main investors in Evvy?
Key investors in Evvy include Catalio Capital Management, General Catalyst, Left Lane Capital.
Will Evvy IPO soon?
No public IPO plans have been announced for Evvy.
How can I track Evvy secondary market activity?
Caplight tracks bids, offers, and trades in Evvy's shares on secondary markets.